Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activitysort descending Investigator Unit Sponsor Date
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction... Contract $105,851.40 Clinical Trial Aaron Wolfson Sarver Heart Center Cytokinetics, Incorporated 09/2020
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer (COMPPARE) Contract $20,713.00 Clinical Trial Shona Dougherty Radiation Oncology University of Florida 03/2020
A Phase II Trial of PET-Directed Therapy using AVD (doxorubicin, vinblastine, and dacarbazine) plus Brentuximab Vedotin Induction Chemotherapy, with or without Brentuximab Vedotin plus Nivolumab... Contract $40,100.00 Clinical Trial Daniel Persky Cancer Center Division Mayo Foundation for Medical Education and Research (Mayo Clinic) 07/2020
A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients with COVID-19 Contract $450,320.00 Clinical Trial Marilyn Glassberg Csete COM Phx Internal Medicine Regeneron Pharmaceuticals, Inc 12/2020
A Prospective, Randomized, Open-Label, Comparative Study to Assess the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) and Best Available Therapy for the Treatment of Serious... Contract $240,575.50 Clinical Trial Bellal Joseph Surgery Parexel International Corporation 03/2020
A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Trac Contract $270,744.00 Clinical Trial Rachna Shroff Cancer Center Division IQVIA RDS Inc. 07/2020
A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3011 in Patients with Advanced Solid Tumors Contract $424,465.24 Clinical Trial Pavani Chalasani Cancer Center Division Covance, Incorporated 09/2020
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy, with an Open Label... Contract $107,762.52 Clinical Trial David Labiner Neurology NCGS Incorporated 03/2020
A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects with Mild to Moderate Coronavirus Disease... Contract $502,490.72 Clinical Trial Thomas Ardiles COM Phx Internal Medicine Pharmaceutical Research Associates 07/2020
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Contract $433,913.00 Clinical Trial Bhupinder Natt Medicine Worldwide Clinical Trials 10/2020
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE in Subjects InDicatEd for TAVR Contract $115,544.00 Clinical Trial Ashish Pershad COM Phx Internal Medicine Boston Scientific Corporation 03/2020
A Three-Arm Study of ME-401 Monotherapy in Subjects with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Follicular Lymphoma (FL), of ME-401 in Combination... Contract $298,700.00 Clinical Trial Daniel Persky Cancer Center Division Clinipace Worldwide 07/2020
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contacts Contract $207,346.24 Clinical Trial Sairam Parthasarathy Medicine Regeneron Pharmaceuticals, Inc 09/2020
Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-Type, Left-Sided Colorectal Cancer Contract $127,173.74 Clinical Trial Aaron Scott Cancer Center Division Academic Gastrointestinal Cancer Consortium 03/2020
A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma Contract $258,643.47 Clinical Trial Jared Robbins Cancer Center Division Regeneron Pharmaceuticals, Inc 02/2020
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H) Grant $32,900.00 Clinical Trial Wei Zhou Surgery Mayo Foundation for Medical Education and Research (Mayo Clinic) 07/2020
A Phase I/II Pilot Trial, Single Arm, Open Label, of Protein-bound Paclitaxel, Cisplatin, And Gemcitabine (GCN) Combined with Tumor Treatment Fields (TTF) in Patient with Metastatic Pancreatic... Contract $161,422.69 Clinical Trial Hani Babiker Cancer Center Division NovoCure 09/2020
Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY) Contract $159,936.00 Clinical Trial Pavani Chalasani Cancer Center Division IQVIA RDS Inc. 02/2020
Clinical, Electrocardiographic, and Cardiac Magnetic Resonance Imaging Risk Factors Associated with Ventricular Tachyarrhythmias in Nonischemic Cardiomyopathy (MARVEN Study) Grant $41,994.00 Clinical Trial Rajesh Janardhanan Sarver Heart Center University of Rochester 07/2020
A Phase I/II Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) for the Treatment of Adults with COVID-19 Contract $275,952.00 Clinical Trial Marilyn Glassberg Csete COM Phx Internal Medicine Celularity, Inc. 09/2020
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair with the Edwards PASCAL Transcatheter ...... Contract $141,792.00 Clinical Trial Ashish Pershad COM Phx Internal Medicine Edwards Lifesciences LLC 06/2020
Elecestrant Monotherapy VS. Standard Of Care For The Treatment Of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, OPEN-LABEL, Active-Controlled Contract $369,650.07 Clinical Trial Pavani Chalasani Cancer Center Division Radius Health, Inc. 02/2020
Collaborative Islet Transplant Registry (CITR) Contract $20,000.00 Clinical Trial Robert Harland Surgery The EMMES Corporation, LLC 07/2020
A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients who are Hospitalized with Pneumonia and Presumed or Confirmed COVID-19 Contract $1,181,507.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Target Health, LLC 10/2020
A Phase 1 Study of ERK1/2 Inhibitor JSI-1187 Administered as Monotherapy and in Combination with Dabrafenib for the Treatment of Advanced Solid Tumors with MAPK Pathway Mutations Contract $643,931.75 Clinical Trial Hani Babiker Cancer Center Division Strategia Therapeutics 06/2020

Pages